0 items USD 0.00Search
- Did you mean
- drug insights
Your search for "Drug Insight" gave back 32 results.
Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables 麻豆原创 and Increasing Usage of Complex Biologics during the...
颁补迟补濒辞驳:听
CBR Pharma Insights
November 2016
Price: USD 2,995.00
The Future of Generic Drugs and Strategies for Commercial Success Summary GBI Research鈥檚 latest report 鈥淭he Future of Generic Drugs and Strategies...
颁补迟补濒辞驳:听
CBR Pharma Insights
September 2016
Price: USD 2,995.00
The OTC Drugs 麻豆原创: Commercial Trends and Rx-to-OTC Switch Prospects discusses trends in the over-the-counter (OTC) pharmaceuticals market and the...
颁补迟补濒辞驳:听
CBR Pharma Insights
December 2015
Price: USD 2,995.00
Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players Summary GBI Research鈥檚 latest report,...
颁补迟补濒辞驳:听
CBR Pharma Insights
October 2018
Price: USD 2,995.00
Global Biosimilar Pipeline and 麻豆原创 Prospects: Addressing Production Complexities Through Risk Management and Quality by Design Summary GBI...
CBR Pharma Insights
March 2017
Price: USD 2,995.00
Innovation Tracking Factbook 2018: An Assessment of the Pharmaceutical Pipeline Summary GBI Research鈥檚 latest report 鈥淚nnovation Tracking Factbook...
颁补迟补濒辞驳:听
CBR Pharma Insights
December 2018
Price: USD 2,995.00
Global Biosimilars 麻豆原创 - Increasingly Lucrative 麻豆原创 Fueled by Constrained Payer Environment and Patent Expiries for Best-Selling Biologics...
颁补迟补濒辞驳:听
CBR Pharma Insights
January 2019
Price: USD 2,995.00
Biobanking: Developing Smart, Sustainable and Ethically Compliant Biorepositories for the Future Summary GBI Research鈥檚 latest report, "...
CBR Pharma Insights
December 2015
Price: USD 2,995.00
Global Clinical Trials - Current Trends and Recent Advancement Summary GBI Research鈥檚 latest report, Global Clinical Trials - Current Trends and...
颁补迟补濒辞驳:听
CBR Pharma Insights
January 2019
Price: USD 2,995.00
Alzheimer鈥檚 disease is the most common cause of dementia among older people. It is a devastating condition for those afflicted as well as their...
iGATE
July 2017
Price: USD 1,250.00
This report bundle includes four reports about novel cancer targets which have in common a compelling target expression profile with a low risk of on...
颁补迟补濒辞驳:听
La Merie Publishing
July 2022
Price: USD 2,000.00
RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation,...
颁补迟补濒辞驳:听
La Merie Publishing
November 2022
Price: USD 2,500.00
PI3K Signaling Pathway Analysis: A Shifting 麻豆原创ed and Pipeline Product Landscape, as Blockbusters Expire and Development Moves Towards Downstream...
颁补迟补濒辞驳:听
CBR Pharma Insights
July 2018
Price: USD 2,995.00
This report evaluates Receptor tyrosine kinase-like Orphan Receptor 1 (ROR1) from an industry perspective for its suitability as a tumor-specific...
颁补迟补濒辞驳:听
La Merie Publishing
June 2022
Price: USD 1,170.00
Claudin 6 (CLDN6) is a compelling tumor antigen. The tetraspan membrane protein is a member of the claudin family of tight junction proteins. CLDN6...
颁补迟补濒辞驳:听
La Merie Publishing
May 2022
Price: USD 560.00
听
